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Abstract
Hereditary spherocytosis is a common hemolytic anemia asso-
ciated with deficiencies in spectrin, the principal structural
protein of the erythrocyte membrane-skeleton. We have exam-
ined 20 different individuals from 10 spherocytosis kindreds
and 2 elliptocytosis kindreds to determine the effects of differ-
ent levels of spectrin deficiency on the viscoelastic properties
of the erythrocyte membrane. Micropipettes were used to per-
form single-cell micromechanical measurements of - 1,000
individual cells to determine the membrane elastic shear modu-
lus, the apparent membrane bending stiffness, and whole cell
recovery time constant for the different cell populations. The
membrane viscosity was calculated by the product of the shear
modulus and the recovery time constant. Results show correla-
tion between the fractional reduction in shear modulus and the
fractional reduction in spectrin content (determined by spectrin
radioimmunoassay) and spectrin density (determined by the
ratios of spectrin to band 3 on electrophoresis gels) suggesting
that membrane shear elasticity is directly proportional to the
surface density of spectrin on the membrane (P < 0.001). The
apparent membrane bending stiffness is also reduced in pro-
portion to the density of spectrin (P < 0.001). The membrane
viscosity is reduced relative to control (P < 0.001), but the
nature of the relationship between spectrin density and mem-
brane viscosity is less clearly defined. These studies document
striking relationships between partial deficiencies of erythro-
cyte spectrin and specific viscoelastic properties of the mutant
membranes.
Introduction
The pathophysiology of hereditary spherocytosis (HS)' has
been the subject of clinical and biophysical investigation for
decades (see Weed [1] and Becker and Lux [2] for reviews).
Early investigators recognized that the basis of the disorder
resided in the red cell itself, and that the cells had decreased
surface-to-volume ratio (S/V), probably due to loss of surface
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area. Further delineation of the underlying mechanism in the
disorder has been possible because of advances occurring over
the past decade both in our knowledge of the molecular com-
position and organization ofthe erythrocyte membrane and in
our understanding and characterization of the mechanical be-
havior of the membrane.
The membrane skeleton is a protein "scaffolding" at the
cytoplasmic surface of the membrane bilayer that gives the
erythrocyte its elastic character and contributes to its stability
(for review see Bennett [3]). The membrane-skeleton consists
primarily ofspectrin, a heterodimer ofalpha and beta subunits
that associate head-to-head with other spectrin heterodimers
to form tetramers and higher order oligomers. These spectrin
oligomers are in turn cross-linked by tail end associations with
short actin protofilaments and protein 4.1 forming a network.
This network is held to the bilayer by associations between
spectrin, ankyrin and the integral protein, band 3, and by
associations between band 4.1 and a subset of the integral
proteins, the glycophorins. Recently, it has been demonstrated
that partial deficiency of spectrin is a general feature of many
different forms of HS (4) and that the magnitude of the defi-
ciency correlates with the clinical severity of the anemia (5).
Concurrent with the growth in understanding of the bio-
chemical aspects of membrane-skeletal structure, the under-
standing and ability to evaluate the mechanical properties of
the erythrocyte membrane have grown in sophistication. (See
Evans and Skalak [6] and Hochmuth and Waugh [7] for
reviews). The membrane has a large resistance to changes in
surface area so that under physiologic conditions the mem-
brane area can be considered constant. (This does not exclude
the possibility that cellular area can be reduced by loss of
membrane fragments, microvesiculation or chemical degrada-
tion.) The membrane also exhibits shear rigidity, an elastic
resistance to extensional deformations of the surface plane at
constant area, that is characterized by the membrane shear
modulus (IA). The elastic resistance of the membrane to
changes in curvature is characterized by the bending stiffness
(B). These elastic coefficients can be used to predict membrane
behavior under static (stationary) loads. To predict membrane
behavior in dynamic situations an additional coefficient, the
membrane viscosity ('i), is needed. While the actual dynamic
behavior of the membrane is complex (8, 9), a single constant
coefficient relating membrane force resultants to the rate of
surface deformation is adequate for characterizing the mem-
brane behavior under physiologic conditions.
The identification and characterization of molecular ab-
normalities in hemolytic anemias coupled with the ability to
accurately measure membrane mechanical properties has pro-
vided important opportunities to learn more about the struc-
ture-function relationship of the red cell membrane skeleton.
In a previous report (10), the force required to form membrane
strands (tethers) from red cells was measured for a number of
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patients with different molecular abnormalities. Although the
tethering force was consistently lower for the abnormal mem-
branes compared to control, the extent of the mechanical dys-
function did not correlate well with the biochemical character-
ization of the membrane defect, suggesting that the biochemi-
cal characterizations may have been incomplete, and that
other yet unidentified molecular lesions were responsible for
the mechanical abnormality. Indeed, subsequent biochemical
analyses identified spectrin deficiencies with abnormal spec-
trin variants in patients with defective spectrin-4. 1 linkages (2)
and patients with reduced ankyrin binding sites (1 1). In a pre-
liminary study of eight individuals, six of whom were known
to be spectrin deficient (12), a reduction in membrane shear
modulus was observed that was similar to the apparent reduc-
tion in the surface density of spectrin on the membrane (as
indicated by the spectrin/band 3 ratio). In the present work we
have taken advantage of the extensive characterization of ab-
solute spectrin content (determined by radioimmunoassay)
and spectrin density (spectrin:band 3 ratios on electrophoretic
gels) in 12 different kindreds (5) to examine the relationship
between spectrin deficiency and the viscoelastic coefficients
that are important for characterizing and predicting the cellu-
lar behavior under physiologic conditions.
Methods
Blood samples were obtained by venipuncture, anticoagulated with
acid-citrate-dextrose, and shipped on ice via overnight carrier to Dr.
Waugh for determination of mechanical coefficients and Dr. Agre for
biochemical analyses. All measurements were performed within 48 h
of phlebotomy. Measurements were obtained on blood from 18 HS
patients from 10 different kindreds, two heterozygous patients from a
family with ovalocytosis and an elongated protein 4.1 variant (13, 14),
one patient with elliptocytosis and an aIT68 spectrin variant (1 1), and
one normal individual who had undergone splenectomy after trauma
(in addition to matched normal controls for each experiment). The
patients are listed in Table I, along with pertinent clinical and genetic
information.
Biochemical measurements
Spectrin density. The normalized spectrin/band 3 ratios were obtained
in conjunction with a recent report (5), with the exception of patient
16, whose data appeared in a separate report (2). After separation from
other cells, red cells were lysed and washed repeatedly until white
membranes were obtained (15). SDS-PAGE was performed according
to the methods of Fairbanks et al. (16) using 3.5-17% nonlinear acryl-
amide gradient slabs. Membranes were dissolved in SDS (1%) and
- 25 ,g of protein was applied to the gel and electrophoresed at 250 V
for 3 h. The gels were stained in Coomassie Brilliant Blue R250 over-
night, then destained until the background became colorless. The ap-
propriate bands were cut from the gel and eluted overnight in 1.0 ml of
25% (vol/vol) pyridine in water (17), and absorbance was measured at
605 nm. The ratio of the absorbance of spectrin to the absorbance of
band 3 was taken as the spectrin/band 3 ratio. For normal cells the
ratio was - 1.0. Five determinations were made for each patient and
control, and the ratio for the patient divided by the ratio for the control
gives the "normalized spectrin/band 3 ratio."
Spectrin content. The spectrin radioimmunoassay measured com-
petition between spectrin in detergent solubilized erythrocytes and
1251-labeled spectrin for a limiting number of sites on immunoadsor-
bents as described (4). Human spectrin was purified (15) and '251I-la-
beled to approximately 2 X 107 cpm/ug (18). The immunoadsorbent
was prepared by incubating formalin fixed protein A-bearing Staphylo-
cocci with high titer serum from rabbits immunized with human spec-
trim (19). Patient and control blood specimens were washed three times
in PBS, diluted to hematocrits of 10%, and exact cell counts were
established by a Coulter counter (Coulter Instruments, Inc., Hialeah,
FL). Aliquots were solubilized by incubation in 1% SDS at 60C for 10
min and serially diluted into radioimmunoassay buffer (150 mM
NaCl, 10 mM NaPO4, pH 7.5, 1 mM NaEDTA, 1 mM NaN3, 1%
(vol/vol) Triton X-100, 1 mg/ml bovine serum albumin, 5 gg/ml pan-
creatic trypsin inhibitor).
The assay was performed in 12 X 75 polystyrene tubes in a 0.2-ml
volume of radioimmunoassay buffer containing 251I-labeled spectrin
(100,000 cpm), dilutions of detergent solubilized erythrocytes (varying
from 1:40 to 1:12,000), and immunoadsorbent (0.5% vol/vol Staphylo-
coccus suspension with sufficient capacity to precipitate 50% of the
'25l-labeled spectrin). After shaking overnight at 4VC, the immunopre-
cipitates were washed twice in 2 M urea, 1% Triton X-100, 0.1 M
glycine, and counted in a gamma counter. Spectrin content for each
patient was compared to that of the control by linear regression of
displacement profiles where immunoprecipitated '25I-labeled spectrin
was plotted against the number of erythrocytes calculated for each
dilution.
Mechanical measurements. Upon receipt, cells were separated
from the plasma by centrifugation and resuspended in PBS (125 mM
NaCl, 25 mM Na2HPO4, 6.2 mM KH2PO4, and 10 MM NaN3) with
serum proteins (3-5 mg/ml bovine serum albumin or 2.0% (vol/vol)
autologous plasma). Before use, all solutions were filtered through
0.2-,um filters to remove bacteria and debris.
A dilute cell suspension was placed in a small chamber (1.0 X 2.0
X 0.1 cm) consisting of a plastic U-shaped spacer between two glass
coverslips. The chamber was sealed with vacuum grease, except at the
open side ofthe "U." A micropipette (0.9-1.2 Mum i.d.) was introduced
through the open side of the "U" and individual cells were aspirated
according to the procedures outlined below. After each cell, the field of
view was shifted to a new location, to minimize exposure ofthe cells to
the high-intensity microscope illumination. Exposure of individual
cells was limited to < 5 min, and the time cells were allowed to remain
in the chamber on the microscope stage was < 45 min. The aspiration
of individual cells was observed and recorded via a television camera.
A data mixer was used to incorporate a digital readout ofthe aspiration
pressure and time into the videorecording. Experiments were per-
formed at room temperature (20-25°C).
Shear modulus and creasing pressure measurements. This method
is essentially the same as previously described (20, 21). Cells were
aspirated in the dimple region at an initial suction between 2.0 and 3.0
mm H20 (- 200-300 dyn/cm2) (Fig. 1 A). Pressure was controlled by
changing the level of a water-filled reservoir with a micrometer, and
was monitored with a pressure transducer (Validyne Engineering
Corp., Northridge, CA: DP103-12). The suction pressure was in-
creased in five to nine increments until creases were observed to form
on the cell surface. The length of the aspirated membrane projection
was measured as a function of pressure from the videorecordings. The
shear modulus (M) was calculated by linear regression to the length,
pressure data pairs according to the equation proposed by Chien (8):
A-R R= CI(L/Rp) + C2,
A
(1)
where C, = 2.45, C2 = -0.603, AP is the aspiration pressure, Rp is the
pipette radius, and L is the length of the aspirated projection.
The pressure at which creases first formed in the cell surface was
also noted (Fig. 1 B). Evans (22) has derived an approximate relation-
ship between the creasing pressure and the membrane bending stiff-
ness. His analysis is based on membrane stability analysis and contains
simplifying assumptions about the membrane geometry and the
membrane force resultants. For cells that are geometrically similar and
aspirated with the same pipette, the creasing pressure should provide
an accurate comparison ofthe bending stiffness ofthe two membranes.
However, the extent to which geometric differences between cell popu-
lations may affect Evans' derived relationship is not known with pre-
cision, and differences in creasing pressure observed between popula-
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Figure 1. Schematic of the mi-
A cromechanical techniques used
to determine membrane visco-
elastic properties. (A) Shear
modulus. Erythrocytes are
_____ aspirated in the dimple region
and the length of the projec-
tion in the pipette is measured
as a function of the aspiration
pressure. (B) Bending stiffness.
When the aspiration pressure
becomes large enough, the
B bending stiffness of the mem-
brane (which stabilizes the
smooth surface geometry) is
overcome, and creases form in
the membrane. The pressure at
which the creases form pro-
vides a measure of the bending
stiffness (22). (C) Membrane
viscosity. Cells that have ad-
hered to the glass surface at a
single point (arrow) are aspi-
rated at the free edge and
stretched into a spindle shape
by withdrawing the pipette
along the surface of the glass.
The cell is released and the time course of the recovery is observed.
The time constant for the recovery is equal to the ratio of the mem-
brane viscosity to the membrane elastic modulus (n = - tj).
tions of cells with significantly different geometries should be inter-
preted cautiously.
Recovery time constant measurements. This procedure has also
been described elsewhere (21, 23). The bottom coverglass of the cell
chamber was pretreated with a dilute, filtered solution ofPBS contain-
ing autologous plasma (2.0-6.0%, vol/vol) to obtain the desired adhe-
siveness between the cells and the glass surface. Cells were allowed to
settle onto the glass surface and remain undisturbed for 20-30 min
during which time they became attached to the glass. A pipette was
used to aspirate the cell opposite to the attachment site and stretch the
cell into a spindle shape (Fig. 1 C). The cell was released, and the time
course of the recovery is recorded. The length-to-width ratio ofthe cell
(LIW) during the recovery is measured as a function of time (t) from
the videorecordings. The time constant for the recovery, tc, is obtained
by least squares regression to the equation for the recovery ofa rectan-
gular membrane strip (23):




The subscript "m" denotes the maximum length-to-width ratio (at
release) and the subscript "oo" denotes the fully recovered state. The
time constant is the ratio of the membrane viscosity (,q) to the shear
modulus (W): tc = WA. In the regression (L/W)m is fixed, and tc and
(LIW)00 are "free" parameters determined by the regression. The
membrane viscosity is calculated by taking the product of the shear
modulus and the recovery time constant: i7 = gtc.
Area and volume measurements. Cells were aspirated into the mi-
cropipette at a pressure sufficient to draw the outer portion into a
sphere (a 6,000 dyn/cm2). The length of the projection, L, and the
radius of the spherical portion outside the pipette RO were measured,
and the area A and the volume V were calculated according to the
following equations:
A = 2irRo(Ro + VR022- Rp2) + 2irRL
V= 2xr(RO3 + (R02 + 2 F&-2 Rp2 + Rp3] + (L-Rp)rRp2.





To avoid bias in selecting cells to characterize a particular population,
an arbitrary field of view was chosen and every cell in the field was
measured.
Statistics. The standard error (SE) for each sample (patient and
control) was calculated from the standard deviation of the sample
(SD):
SE = SD/fn - 1, (7)
where n is the sample size. The standard error ofthe ratio (C = A/B) or
of the product (in calculating x7) (C = A . B) were obtained via the
following approximate relationship:
(SEc)2 SEA)2 (SEB)2
t<C>)~t<> tB>) ' (8)
where K> indicates the average value of the sample, product, or ratio.
Results
Blood samples from a total of 21 patients were examined
(Table I), including one (17, 1 7a) who was tested both pre- and
postsplenectomy. Patients 19 and 20 are not spectrin deficient,
but have an abnormal variant of the protein band 4.1. Patient
21 is hematologically normal, and represents a splenectomized
control. The membrane spectrin density (spectrin/band 3
ratio), erythrocyte spectrin content (measured by radioimmu-
noassay), the membrane shear modulus, the creasing pressure
and the whole cell recovery time constant were determined for
each sample (Table II). A minimum of 10 different cells from
each sample were tested for shear modulus and creasing pres-
sure and at least 16 cells were tested for the recovery time
constant determination. Results for each patient were normal-
ized relative to a matched control population that had been
drawn concurrently and shipped on ice with the abnormal
samples. For shear modulus and creasing pressure measure-
ment, controls and abnormal cells were measured with the
same pipette, and controls were tested before and after the
abnormal cells to insure that the condition of the cells and the
pipette did not change during the course of the experiment.
The results are summarized in Table II, which lists the normal-
ized values of the relevant parameters for each patient. Stan-
dard errors ofthe ratios of the mechanical properties are listed
in the table. Biochemical measurements were repeatable
within ±5.0% of the average for the spectrin/band 3 ratios and
±7.0% for radioimmunoassay. The results for each mechanical
parameter are shown as a function of spectrin/band 3 ratio or
spectrin radioimmunoassay in Figs. 3-6.
Cellular morphology. Most of the patients in the present
study had some cells that were morphologically "normal", i.e.,
they were biconcave disks ofapproximately the same diameter
as controls. In general, the distribution of cell size was broader
for the abnormal samples than for controls, and there were
some cells too small or too spherical to be used for mechanical
studies. For all but seven of the patients, > 80% of the cells
were suitable for mechanical measurements. The exceptions
include the most severely affected recessive patients and pa-
tient 18, who was poikilocytic. For patients 1, 2, 6-8, and 18,
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Table I. Clinical and Genetic Analysis ofPatients
Family Patient Clinical severity Splenectomy Genetic or biochemical abnormality Zygosity
Recessive spherocytosis
A 1 (Sister) Nearly lethal + a II Spectrin variant Homozygote
2 (Sister) Nearly lethal + a II Spectrin variant Homozygote
3 (Mother) Asymptomatic a II Spectrin variant Heterozygote (carrier)
4 (Distant cousin) Severe + a II Spectrin variant Homozygote
B 5 (Male) Nearly lethal + a Spectrin RFLP* Homozygote
C 6 (Male) Nearly lethal + a II Spectrin variant Homozygote
D 7 (Brother) Severe + a II Spectrin variant Homozygote
8 (Sister) Moderate + a II Spectrin variant Homozygote
E 9 (Sister) Nearly lethal + Unidentified Presumed homozygote
10 (Brother) Nearly lethal + Unidentified Presumed homozygote
Dominant spherocytosis
F 11 (Mother) Mild + Unidentified Heterozygote
12 (Son) Mild Unidentified Heterozygote
G 13 (Female) Mild + Unidentified Heterozygote
H 14 (Mother) Moderate + Unidentified Heterozygote
15 (Son) Moderate Unidentified Heterozygote
I 16 (Female) Moderate + Spectrin-4.1 assoc. Heterozygote
J 17 (Female) Moderate Unidentified Heterozygote
17A (Same pt.) Moderate + Unidentified Heterozygote
Elliptocytosis
K 18 (Female) Moderate + aIT68 Spectrin variant (and Homozygote
reduced ankyrin sites)
L 19 (Father) Asymptomatic Elongated 4.1 variant Heterozygote
20 (Son) Asymptomatic Elongated 4.1 variant Heterozygote
Asplenic control
M 21 (Male) Normal + None
* RFLP, restriction fragment length polymorphism/homozygote with parental consanguinity. I Described in references 2, 13, 14, and 35.
only 7-20% of the cells were suitable for mechanical measure-
ments, and for patient 4, 40-60% of the cells were suitable for
measurement. For these patients, selectivity in choosing cells
for measurement may have resulted in average values for me-
chanical properties that are not representative of the total cell
population (used for biochemical studies). This situation is
regrettable, but because of the technical limitations of our
measurements and the nature ofthe abnormal cell population,
it is unavoidable. Nevertheless, if the selected cells are mor-
phologically closer to normal than the average, it is very likely
that measured viscoelastic coefficients actually underestimate
the true extent ofthe mechanical abnormality. For most of the
patients studied, it was possible to take a relatively unbiased
sample of the population.
Sphericity. The primary morphological difference between
HS cells and controls is increased sphericity. There is also a
slight reduction in mean surface area for the HS cells, but
because the distribution of areas within the populations is
large, there is typically greater than 80% overlap in the distri-
butions of area for normal and abnormal cells. This is illus-
trated in Fig. 2, which shows the sphericity plotted as a func-
tion of area for cells of patient 4 and the matched control.
Shear modulus. Striking correlations were observed when
either membrane spectrin density (Fig. 3) or erythrocyte spec-
trin content (Fig. 3, inset) were plotted against shear modulus
(Pm.0 < 0.001).2 These two methods for spectrin quantitation
provide somewhat different information. Spectrin density
(spectrin/band 3 ratio) is a unitless comparison of membrane
spectrin and band 3, the latter being an index of membrane
surface area. (Only about 15% of band 3 is tethered to the
membrane skeleton [24].) The plot for all data points of spec-
trin density vs. shear modulus appears to be curvilinear (Fig. 3,
dashed line). Sampling error was a concern for the least nor-
mal samples, and when data from the more normal samples
were analyzed (spectrin/band 3 > 0.6), a linear relationship
was identified with y intercept = 0.13, and slope = 0.83 (r
= 0.79). These compare well with the values anticipated if
shear modulus is directly proportional to spectrin density, y
intercept = 0, slope = 1.
The correlation between erythrocyte spectrin content (de-
termined by radioimmunoassay) and shear modulus is also
notable (Fig. 3, inset), with spectrin content expressed as frac-
tion of normal control. The correlation with the shear modu-
lus is statistically convincing, yet the linear relationship has a y
intercept = 0.45 and slope = 0.5. Although erythrtcyte spec-
trin content measurement by radioimmunoassay is a more
reliable measurement than spectrin density, the spectrin con-
2. Pm=o is the probability that the slope of the linear regression (m) is
zero, i.e., the probability that there is no correlation.
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Table II. Erythrocyte Membrane Spectrin Content and Material Properties
Spectrin Spectrin/band 3 Recovery
Family Patient radioimmunoassayt ratiot Shear modulus Creasing pressure time constant Membrane viscosity
fraction ofcontrol fraction ofcontrol I/pl,±SE PC/PCO±SE tl/tw,,SE nl//ro±SE
Recessive spherocytosis
A 1 0.34 0.54 0.62±0.04 0.72±0.04 0.62±0.07 0.39±0.05
2 0.31 0.52 0.62±0.03 0.67±0.03 0.76±0.07 0.47±0.05
3 0.98 0.97 0.82±0.09 0.78±0.04 - -
4 0.59 0.68 0.73±0.05 0.58±0.04 0.85±0.06 0.62±0.06
0.85±0.05 0.66±0.05
B 5 0.45 0.73 0.77±0.04 0.77±0.03 0.85±0.05 0.66±0.05
C 6 0.33 0.55 0.61±0.04 0.64±0.03 0.87±0.07 0.53±0.06
D 7 0.51 0.65 0.61±0.03 0.66±0.02 0.76±0.04 0.47±0.03
8 0.57 0.71 0.73±0.05 0.66±0.03 0.97±0.07 0.71±0.07
E 9 0.34 0.43 0.62±0.09 0.57±0.04 0.69±0.04 0.43±0.07
10 0.33 0.43 0.63±0.07 0.53±0.04 0.62±0.05 0.39±0.05
Dominant spherocytosis
F 11 0.82 0.82 0.89±0.07 0.73±0.04 0.73±0.06 0.65±0.08
12 0.77 0.89 0.82±0.04 0.71±0.03 0.82±0.07 0.67±0.06
G 13 0.75 0.88 0.92±0.04 0.92±0.05 1.18±0.09 1.09±0.09
H 14 0.69 0.80 0.72±0.04 0.67±0.03 1.37±0.12 0.98±0.10
15 0.68* 0.86 0.70±0.04 0.69±0.04 1.03±0.09 0.72±0.08
I 16 0.66* 0.80 0.83±0.08 0.75±0.07 0.75±0.16 0.62±0.15
J 17 0.81 0.93 0.90±0.05 0.85±0.03 0.92±0.07 0.82±0.08
17A 0.80 0.90 0.82±0.05 0.83±0.04 0.82±0.05 0.67±0.06
Elliptocytosis
K 18 0.55* 0.70 0.72±0.10 0.63±0.05 1.06±0.14 0.76±0.15
L 19 1.0* 0.99 0.97±0.06 0.92±0.05 0.66±0.03 0.64±0.05
20 1.0* 1.00 1.04±0.05 1.03±0.05 0.74±0.05 0.77±0.06
Asplenic control
21 1.06 0.89 0.99±0.03 0.92±0.06 1.03±0.07 1.02±0.07
* Spectrin content from five individuals was determined from the normalized ratio of spectrin relative to band 3 (sp/b3) eluted with 25% (vol/
vol) pyridine/H20 from Coomassie Blue stained SDS-PAGE slabs. Over-estimation of spectrin was corrected by comparing the sp/b3 with the
correlation of sp/b3 to spectrin content as measured by radioimmunoassay (5). * RIA measurements were repeatable within 7.0% of the aver-
age value. Spectrin/band 3 measurements were repeatable within 5.0% of the average value.
tent does not reflect any secondary loss of unsupported mem-
brane (containing phospholipid and untethered band 3). It has
been shown with a band 3 radioimmunoassay that erythro-
cytes with gross deficiencies of spectrin have smaller, presum-
ably secondary deficiencies of band 3 as well as minor reduc-
tions of other membrane proteins (4). Measurements of cell
surface area using micropipettes indicate that the average sur-
face area of cells from HS patients 4, 5, 8, 11-14 was up to 10%
less than control. Thus, the reduction in spectrin content for
the HS membranes is in part compensated by reductions of
membrane surface area, so that the surface density of spectrin
on the membrane is reduced to an intermediate level. For this
reason, we expect reductions in the spectrin density (spectrin/
band 3 ratio) to correspond more directly to reductions in the
elastic shear modulus.
Important controls were included in these studies. Splenec-
tomy has a small effect upon the spectrin/band 3 ratio, but this
did not appear to alter the shear modulus when measured in
an individual before and after splenectomy (patient 17, 17a),
or in a normal individual who had undergone splenectomy
following trauma (patient 21). Likewise, when assessed by per-
centage of circulating reticulocytes, mean cell age did not ap-
pear to have important effects either on the biochemical ab-
normality or on membrane elasticity: similar shear moduli
were measured in the splenectomized and unsplenectomized
patients int families F and H as well as patient 17. Furthermore,
the relationship between spectrin density and shear modulus is
not unique for HS. Individuals with elliptocytosis resulting
from an elongated protein 4.1 variant (patients 19 and 20) and
an individual homozygous for an abnormal alpha I spectrin
variant and intermediate spectrin deficiency (patient 18) all
fell close to the profile for the HS patients.
Finally, neither an increase in sphericity nor a decrease in
surface area has an effect on the measured value of the shear
modulus. Populations of normal cells suspended in normal
(295 mosmol PBS) and hypotonic (220 mosmol PBS) buffers
had different sphericities (0.80 at 295 mosmol and 0.87 at 220
mosmol, P < 0.001),3 but exhibited similar shear moduli: at
295 mosmol, <A> = 0.0044, SD = 0.0005, n = 22; at 220
mosmol, <i> = 0.0043, SD = 0.0006, n = 14 (not significantly
different by Student's t test). Similarly, when large normal cells
(A > 150 em2) were compared with small normal cells (A
< 135 Am2), there was also no significant difference in the
3. P is the probability that the means of the two populations are equal
(compared to not equal) calculated from the Student's t distribution.










mean shear moduli. For large cells ((A> = 158 am2), <;z>
= 0.0043, SD = 0.0007, n = 10; for small cells ((A> = 129
Am2), (M> = 0.0044, SD = 0.0005, n = 16. Thus, the differ-
ences between abnormal and control populations that we have
observed are not the result of differences in cell geometry, but
reflect differences in the intrinsic properties of the membrane.
Creasing pressure. The pressure at which cells were ob-
served to crease also decreased with membrane spectrin den-
sity (see Fig. 4). Because of severe shape abnormalities, the
observed reduction in creasing pressure for patients 1, 2, 6, 9,
10, and 18 may be due, in part, to geometric differences be-
tween the two cell populations, and may not be completely
attributable to abnormally low bending stiffness.
Recovery time constant and membrane viscosity. The re-
sults for the recovery time constant and membrane viscosity
are shown in Figs. 5 and 6. For most of the patients, the
recovery time constant was reduced compared with control.
Consequently, the membrane viscosity (equal to the product
of the shear modulus and the time constant) is reduced even
more than the shear modulus. This result indicates that the
dependence of membrane viscosity on spectrin density is of
order greater than one. Furthermore, it appears that the con-
tribution of shear modulus (Fig. 3) is considerably more im-
portant than the contribution of recovery time constant (Fig.
5) to the observed correlation between reduced spectrin con-
tent and reduced membrane viscosity.
Discussion
Shear modulus. The similarity between the reduction in shear
modulus and reductions in spectrin density and content is
particularly interesting considering the thermodynamic
meaning of the shear modulus. Elastic deformation of a sur-
face requires energy, which is stored by the constituent mole-
cules and recovered (or dissipated) during the return to the
undeformed state. The shear modulus is a measure of the en-
ergy needed to deform the surface, per unit area, per unit
deformation (6, 12). In general, this energy depends on the
Figure 2. Sphericity plotted as a function of area for
the cells of patient 4 (*) with matched controls (o).
Note that although the mean area of the HS popula-
tion is significantly less than control there is consider-
able overlap in surface area distribution between the
two populations. Also note that the sphericity of the
HS population is distinctly higher than control.
KA>Hs = 122 'sm2, SD = 10, n = 59; <A>)ontrO = 132
150. JAm2, SD = 10, n = 60; P < 0.001. <Sph>Hs = 0.87,
SD = 0.02, n = 59; (Sph>ot,,t, = 0.81, SD = 0.02, n
= 60;P<0.001.
intrinsic stiffness of the molecules, the magnitude of the con-
formational change, and the number of molecules in the sur-
face. The intrinsic molecular stiffness depends ultimately on
the primary structure of the protein; the magnitude of the
conformational change depends on the nature ofthe deforma-
tion and network topology; and the density of molecules on
the surface should be reflected by the spectrin/band 3 ratio.
The present results indicate that (i) spectrin is the main energy
storing molecule on the red cell membrane for elastic shear
deformation, and (ii) in general, the intrinsic molecular stiff-
ness and network topology are not significantly affected by the
disorders, and the shear modulus depends simply on the sur-
face density of spectrin in the membrane. These conclusions
are consistent with the ultrastructural observations ofLiu et al.
(25) indicating that although the number of spectrin tetramers
per actin protofilament is reduced in spectrin-deficient mem-
branes, the normal organization of the skeleton (protofila-
ments of actin joined by spectrin oligomers) is found.
Data for the patients with the most severe spectrin defi-
ciencies show less than expected reductions in shear modulus.
As we mentioned in Results, this may be due to the necessity
to select cells for measurement from a relatively small fraction
of the total cell population because of the extensive geometric
abnormalities found in these samples. It is interesting that the
smallest values measured for the shear modulus are 60% of
control, regardless of the reduction in spectrin density for the
total population. If we have selected cells with the highest
spectrin content for our mechanical measurements, this sug-
gests that a cell must have at least 60% of normal spectrin
density to maintain an approximately "normal" geometry.
However, gradient separation techniques have failed to iden-
tify populations ofcells with higher spectrin densities (data not
shown), and it is not known how broad the distribution of
spectrin densities within a cell population may be.
Observation of reductions in bending stiffness similar to
the reduction in spectrin/band 3 ratio was unexpected. The
bending stiffness of the membrane arises from its large resis-
tance to changes in surface area (see Evans and Skalak [6] for
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Figure 3. The relationship between spectrin density or spectrin con-
tent (inset) and the membrane shear modulus. Values are expressed
as fractions of matched controls. Data for different abnormalities are
coded as follows: A recessive HS, splenectomy; A recessive HS, hetero-
zygote; o dominant HS, splenectomy; * dominant HS; o elliptocy-
tosis, a spectrin variant; * elliptocytosis, 4.1 variant; X control, sple-
nectomy. The solid line is the linear regression to the data for spec-
trin density greater than 0.6: y intercept = 0.13, slope = 0.83, r
= 0.79, Pm=O < 0.001, n = 17. Dashed curve shows curvilinear (qua-
dratic) appearance of the dependence of shear modulus on spectrin
density when all data are included. The cross at the upper left indi-
cates plus or minus the average standard error for the shear modulus
ratio and the confidence interval (±0.05) for the spectrin/band 3
ratio. For spectrin content (inset) y intercept = 0.45, slope = 0.50, r
= 0.90, Pm=O < 0.001, n = 22.
details). Recent observations by Evans and Needham (26) of
the area compressibility ofcholesterol-containing lipid bilayers
indicate that much or all of the resistance of the red cell mem-
brane to area change might be attributable to the membrane
bilayer. Furthermore, it is intuitively unlikely that an elasto-
meric structure such as the membrane skeleton, that has such a
small resistance to extensional deformation, could contribute
significantly to the resistance to area change, which is charac-

















Spectrin Density, Spectrin/Band 3
(fraction of control)
Figure 4. Relationship between spectrin density and creasing pres-
sure (bending stiffness). Solid line shows linear regression to samples
not likely to be affected by geometric abnormalities (normalized
spectrin density > 0.6). The y intercept = 0.03, slope = 0.89, r
= 0.79, Pm.0o < 0.001, n = 17. Dashed line is the linear regression to
all of the data: y intercept = 0.30, slope = 0.58, r = 0.79, Pm=o
< 0.001, n = 22. Data symbols are defined in the legend of Fig. 3.
The cross at the upper left indicates plus or minus the average stan-
dard error for the creasing pressure ratios and the confidence interval
for the spectrin/band 3 ratio.
larger than the membrane shear modulus (500 dyn/cm com-
pared with 0.007 dyn/cm). One possible explanation for our
observations is that the spectrin may alter the arrangement or
composition of the bilayer. A preliminary report documents
abnormal phospholipid organization in membranes from a














Spectrin Density, Spectrin/Band 3
(fraction of control)
Figure 5. Relationship between spectrin density and recovery time
constant. Data symbols are defined in the legend of Fig. 3. The
dashed line shows a linear regression to the data, but there was no
significant correlation between recovery time constant and spectrin
density (r = 0.32). The cross at the upper left indicates plus or minus
the average standard error for the time constant ratios and the confi-
dence interval for the spectrin/band 3 ratio.












Spectrin Density, Spectrin/Band 3
(fraction of control)
Figure 6. Relationship between spectrin density and membrane vis-
cosity. Dashed line shows the linear regression to the data: y inter-
cept = 0.08, slope = 0.79, r = 0.71, Pm.0 < 0.001, n = 21. For data
with a normalized spectrin density > 0.6, no significant correlation
was observed (r = 0.35, curve not shown). Data symbols are defined
in the legend of Fig. 3. The cross at the upper left shows plus or
minus the average standard error of the viscosity ratios and the con-
fidence interval for the spectrin/band 3 ratio.
Evans and Needham (26) have observed that the area modulus
of cholesterol-containing bilayers is reduced when protein is
added to the membrane, indicating that the presence of pro-
tein may alter the partitioning of the cholesterol/phospholipid
in the surface. Thus, it appears likely that the apparent reduc-
tion in bending stiffness that we have observed is due to an
indirect effect of spectrin on the organization or composition
of the membrane bilayer.
The lack ofeffect ofabnormality in band 4.1 on membrane
bending stiffness and shear elasticity demonstrates an impor-
tant distinction between the function of spectrin and the func-
tion of band 4.1. Takakuwa and co-workers (28) have demon-
strated an important role for band 4.1 in maintaining red cell
membrane stability under large shear stresses. The present re-
sults indicate that an abnormal protein 4.1 variant resulting in
elliptocytosis did not contribute measurably to shear elasticity
when the forces on the cell are small compared to forces
needed to cause membrane fragmentation. Thus, spectrin ap-
pears to determine the membrane response to small forces, but
band 4.1 contributes to the stability of the membrane when it
is subjected to large forces.
It is interesting that the membrane viscosity for these ellip-
tocytic membranes is lower than normal (see Table II, patients
19 and 20). This observation is somewhat surprising because
the variant band 4.1 is larger than the normal molecule, and a
larger molecule might be expected to increase cellular viscos-
ity. At the present time, however, it is not known ifthe number
of copies of the variant molecule is normal. (A decrease in
number of molecules would be expected to reduce membrane
viscosity.)
The membrane viscosity of the spectrin-deficient cells did
not follow the same pattern of variation as did the membrane
shear modulus or the bending stiffness. Generally, the viscosity
was more markedly reduced than the shear modulus, although
this was not always the case. These observations might have
been expected for two reasons: first, the dependence of viscos-
ity on protein concentration is expected to be nonlinear ac-
cording to molecular theories of viscosity. In these molecular
theories (29) the viscosity depends not only on the density of
molecules, but also on the number of entanglements between
molecules (which increases with molecular concentration).
Thus, the viscosity of the membrane is expected to depend on
spectrin density raised to a power greater than one. Second,
there is evidence that the membrane viscosity is more sensitive
to environmental factors than the shear modulus. For exam-
ple, the temperature dependence ofthe viscosity is much larger
than the temperature dependence of the shear modulus
(30, 31).
Of more relevance than temperature variation, is the ob-
servation that the viscosity depends strongly on intracellular
hemoglobin concentration (MCHC) (32, 33). Because of this,
differences in cell age might affect our observations of mem-
brane viscosity. Because "young" cells are thought to be less
dense (i.e., have a lower MCHC), and because spectrin-defi-
cient cells are likely to have shortened lifetimes resulting in a
relatively "young" population ofcells, it is possible that part of
the reduction in viscosity we have observed may be due to the
youth of the abnormal cell populations. On the other hand,
loss ofmembrane surface in HS characteristically increases the
MCHC, which would raise the viscosity. In any case, it should
be emphasized that neither the spectrin content nor the mem-
brane shear modulus are appreciably affected by cell age (5,
34), and the differences in shear modulus between normal and
abnormal populations are not attributable to differences in
cell age.
Single-cell, micropipette experiments are designed to assess
the intrinsic material properties of the membrane. Slight geo-
metric differences between cells are not expected to affect the
outcome of the measurements. Our observation that the mea-
sured value ofthe shear modulus ofnormal cells is not affected
by differences in cell surface area or sphericity confirm this
expectation. Thus, the differences we have observed between
normal and abnormal populations of cells reflect differences in
the intrinsic properties of the membranes, and are not the
result of differences in cellular geometry.
The present study documents the effect of spectrin defi-
ciency on the viscoelastic properties oferythrocyte membrane.
Similarities between the fractional reduction in shear modulus
and the fractional reduction in spectrin/band 3 suggest that, in
general, membrane shear elasticity is directly proportional to
the surface density of spectrin on the membrane. The apparent
membrane bending stiffness also appears to be reduced in
proportion to the density of spectrin, but the prevailing view
that bending stiffness arises from the membrane bilayer leads
us to propose that the reduction in bending stiffness may be
due to an indirect effect of spectrin on the composition and/or
molecular organization of the membrane bilayer. The mem-
brane viscosity is also reduced relative to control, but the na-
ture of the relationship between spectrin density and mem-
brane viscosity is not clearly delineated.
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